amitriptyline hydrochloride 50 MG perphenazine 4 MG Oral Tablet
INDICATIONS AND USAGE Perphenazine and amitriptyline hydrochloride tablets are recommended for treatment of (1) patients with moderate to severe anxiety and/or agitation and depressed mood, (2) patients with depression in whom anxiety and/or agitation are severe, and (3) patients with depression and anxiety in association with chronic physical disease. In many of these patients, anxiety masks the depressive state so that, although therapy with a tranquilizer appears to be indicated, the administration of a tranquilizer alone will not be adequate. Schizophrenic patients who have associated depressive symptoms should be considered for therapy with perphenazine and amitriptyline hydrochloride tablets.
Mylan Pharmaceuticals Inc.
ROUND PURPLE MYLAN 73
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED
PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE Tablets, USP are available in the following combinations: DOSAGE FORM ACTIVE INGREDIENT 2 mg/10 mg Perphenazine, USP 2 Amitriptyline hydrochloride, USP 10 2 mg/ 25 mg Perphenazine, USP 2 Amitriptyline hydrochloride, USP 25 4 mg/10 mg Perphenazine, USP 4 Amitriptyline hydrochloride, USP 10 4 mg/25 mg Perphenazine, USP 4 Amitriptyline hydrochloride, USP 25 4 mg/50 mg Perphenazine, USP 4 Amitriptyline hydrochloride, USP 50 The 2 mg/10 mg combination tablets are white, film-coated, round, unscored tablets debossed with MYLAN on one side of the tablet and 330 on the other side. They are available as follows: NDC 0378-0330-01 bottles of 100 tablets NDC 0378-0330-05 bottles of 500 tablets The 2 mg/25 mg combination tablets are purple, film-coated, round, unscored tablets debossed with MYLAN on one side of the tablet and 442 on the other side. They are available as follows: NDC 0378-0442-01 bottles of 100 tablets NDC 0378-0442-05 bottles of 500 tablets The 4 mg/10 mg combination tablets are blue, film-coated, round, unscored tablets debossed with MYLAN on one side of the tablet and 727 on the other side. They are available as follows: NDC 0378-0042-01 bottles of 100 tablets The 4 mg/25 mg combination tablets are orange, film-coated, round, unscored tablets debossed with MYLAN on one side of the tablet and 574 on the other side. They are available as follows: NDC 0378-0574-01 bottles of 100 tablets NDC 0378-0574-05 bottles of 500 tablets The 4 mg/50 mg combination tablets are purple, film-coated, round, unscored tablets debossed with MYLAN on one side of the tablet and 73 on the other side. They are available as follows: NDC 0378-0073-01 bottles of 100 tablets Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Protect from light. Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure. PHARMACIST: Dispense a Medication Guide with each prescription. * Poisindex Toxicologic Management. Topic: Antidepressants, Tricyclic. Micromedex Inc. Vol 85.
More pills like ROUND MYLAN 73